Morocco Reports First Mpox Case Amid Ongoing Global Outbreak
Xcell Biosciences Advances Labcorp Collaboration With Novel Platform for Automated Cell and Gene Therapy Manufacturing
Express News | Labcorp to Acquire Select Outreach Services From Ballad Health
Market Participants Recognise Labcorp Holdings Inc.'s (NYSE:LH) Earnings
Investors in Labcorp Holdings (NYSE:LH) Have Seen Favorable Returns of 59% Over the Past Five Years
Baird Maintains Labcorp Holdings(LH.US) With Buy Rating, Raises Target Price to $278
Baird analyst Eric Coldwell maintains $Labcorp Holdings(LH.US)$ with a buy rating, and adjusts the target price from $277 to $278.According to TipRanks data, the analyst has a success rate of 56.0%